The Lantern Vol. 28, No. 2, Spring 1961

• A New Bedlam • A Priori • Germ Warfare • Verse for a Sympathy Card • On Lamartine\u27s Crucifix • On Art • Hope • Hymn to the Morning • An Educator Speaks • Come Out • Insemination • A Day\u27s Hope • Laura • Walking Together • 20 September 1960 • 15 October 1960 • The Governor\u27s Dog • One of the Gang • Poem • Knowledge is Freedom • To Conservative Child • Seventeen American Skating Careers at the Zenithhttps://digitalcommons.ursinus.edu/lantern/1080/thumbnail.jp

Lack of associations of ten candidate coronary heart disease risk genetic variants and subclinical atherosclerosis in four U.S. populations: The Population Architecture using Genomics and Epidemiology (PAGE) study

A number of genetic variants have been discovered by recent genome-wide association studies for their associations with clinical coronary heart disease (CHD). However, it is unclear whether these variants are also associated with the development of CHD as measured by subclinical atherosclerosis phenotypes, ankle brachial index (ABI), carotid artery intima-media thickness (cIMT) and carotid plaque

Nutrient and Chemical Properties of Aging Golf Course Putting Greens as Impacted by Soil Depth and Mat Development

Nutrient and chemical changes in turfgrass sand-based root zones are not well understood. This study was conducted to characterize nutrient and chemical properties in putting greens influenced by root zone mixture and establishment treatment, putting green age, and soil depth. Putting greens were constructed and established with Agrostis stolonifera L. in sequential years from 1997 to 2000. Treatments included root zone mixtures of 80:20 (v:v) sand and sphagnum peat and 80:15:5 (v:v:v) sand, sphagnum peat, and soil, and accelerated versus controlled establishment. In the establishment year, the accelerated treatment received 2.6-, 3.0-, and 2.6-fold more nitrogen, phosphorus, and potassium, respectively, than the controlled treatment. Soil samples were taken in Fall 2001, Spring 2004, and Summer 2004 and were analyzed for nutrient and chemical properties such as pH, cation exchange capacity (CEC), organic matter (OM), total soluble salts (TSS), and 12 nutrients. The root zone mixture and establishment treatments had minimal effects on most nutrient and chemical properties with the exception of phosphorus and pH. Cation exchange capacity, OM, TSS, and all nutrients decreased with soil depth, whereas soil pH increased. The putting green age × soil depth interaction was significant for many of the nutrient and chemical properties, but separating soil samples into mat and original root zone instead of predetermined soil sampling depths eliminated most of these interactions. The mat layer had higher CEC and OM values and nutrient concentrations and lower pH values than the original root zone mixture

Postcard, The Studio Honors 2015, 2015

The Studio@620 presents the 2015 Studio Honors celebrating 11 years of building community on Saturday October 10th at the University of South Florida Ballroom in St. Petersburg. Last year\u27s Honors celebration was the buzz of the \u27burg after an exciting night of entertainment, so don\u27t miss this year\u27s happening! The evening will be dedicated to Gary Mormino, Frank E. Duckwall, Florida Professor of History Emeritus at USF St. Petersburg, and posthumously to Mr. Paul Barco Sr., a Community Business Leader on The Deuces.https://digitalcommons.usf.edu/bdj_studioat620_postcards/1346/thumbnail.jp

Lack of associations of ten candidate coronary heart disease risk genetic variants and subclinical atherosclerosis in four U.S. populations: The Population Architecture using Genomics and Epidemiology (PAGE) study

BACKGROUND: A number of genetic variants have been discovered by recent genome-wide association studies for their associations with clinical coronary heart disease (CHD). However, it is unclear whether these variants are also associated with the development of CHD as measured by subclinical atherosclerosis phenotypes, ankle brachial index (ABI), carotid artery intima-media thickness (cIMT) and carotid plaque. METHODS: Ten CHD risk single nucleotide polymorphisms (SNPs) were genotyped in individuals of European American (EA), African American (AA), American Indian (AI), and Mexican American (MA) ancestry in the Population Architecture using Genomics and Epidemiology (PAGE) study. In each individual study, we performed linear or logistic regression to examine population-specific associations between SNPs and ABI, common and internal cIMT, and plaque. The results from individual studies were meta-analyzed using a fixed effect inverse variance weighted model. RESULTS: None of the ten SNPs was significantly associated with ABI and common or internal cIMT, after Bonferroni correction. In the sample of 13,337 EA, 3,809 AA, and 5,353 AI individuals with carotid plaque measurement, the GCKR SNP rs780094 was significantly associated with the presence of plaque in AI only (OR = 1.32, 95% confidence interval: 1.17, 1.49, P = 1.08 × 10(−5)), but not in the other populations (P = 0.90 in EA and P = 0.99 in AA). A 9p21 region SNP, rs1333049, was nominally associated with plaque in EA (OR = 1.07, P = 0.02) and in AI (OR = 1.10, P = 0.05). CONCLUSIONS: We identified a significant association between rs780094 and plaque in AI populations, which needs to be replicated in future studies. There was little evidence that the index CHD risk variants identified through genome-wide association studies in EA influence the development of CHD through subclinical atherosclerosis as assessed by cIMT and ABI across ancestries

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1-3). In an evaluation at 24 hospitals in 14 states,* the effectiveness of partial or full vaccination† with Pfizer-BioNTech or Moderna vaccines against COVID-19-associated hospitalization was assessed among adults aged ≥65 years. Among 417 hospitalized adults aged ≥65 years (including 187 case-patients and 230 controls), the median age was 73 years, 48% were female, 73% were non-Hispanic White, 17% were non-Hispanic Black, 6% were Hispanic, and 4% lived in a long-term care facility. Adjusted vaccine effectiveness (VE) against COVID-19-associated hospitalization among adults aged ≥65 years was estimated to be 94% (95% confidence interval [CI] = 49%-99%) for full vaccination and 64% (95% CI = 28%-82%) for partial vaccination. These findings are consistent with efficacy determined from clinical trials in the subgroup of adults aged ≥65 years (4,5). This multisite U.S. evaluation under real-world conditions suggests that vaccination provided protection against COVID-19-associated hospitalization among adults aged ≥65 years. Vaccination is a critical tool for reducing severe COVID-19 in groups at high risk